GlassScriptPhysician profile
Eric M Ridgway
NPI 1811073364
$3,219.78
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $431 · 2020: $840 · 2021: $904 · 2022: $805 · 2023: $239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $239.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $238.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $850.34 | 2019-2023 | Farxiga |
| Glaxosmithkline, LLC. | $468.15 | 2019-2023 | Shingrix |
| Novo Nordisk INC | $278.41 | 2019-2023 | Ozempic, Rybelsus |
| Lilly USA, LLC | $262.25 | 2020-2023 | Mounjaro |
| Abbvie INC. | $199.95 | 2021-2023 | |
| Allergan, INC. | $180.33 | 2019-2020 | |
| Astellas Pharma US INC | $139.62 | 2020-2023 | Myrbetriq |
| Amarin Pharma, INC. | $132.00 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $130.98 | 2019-2023 | Verquvo, Steglatro, Januvia |
| Pfizer INC. | $118.85 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $114.12 | 2019-2022 | |
| Amgen INC. | $95.23 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $76.38 | 2022-2023 | |
| Eisai INC. | $70.46 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $37.90 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultragenyx Pharmaceutical INC. | $29.00 | 2020-2021 | |
| Sunovion Pharmaceuticals INC. | $24.42 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $11.39 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Ridgway listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.